Featured Research

from universities, journals, and other organizations

Medicare plans understate risky prescribing rates

September 30, 2013
Brown University
An analysis of a quality measure that Medicare Advantage plans self-report to the government finds that the insurers almost always err in their own favor. More elderly receive high-risk medications than the plans acknowledge.

A new study reveals widespread inaccuracy in a quality measure that is self-reported by Medicare Advantage health plans. Researchers found that the vast majority in a sample of 172 such insurers significantly understated their rate of high-risk medication prescriptions.

Related Articles

The average rate of prescribing at least one of about 100 medicines deemed risky for the elderly was 26.9 percent of patients over 65, according to the researchers' calculations, compared to the 21.1 percent of patients reported by the plans. The average plan, therefore, reported a rate that was 5.8 percentage points better than it actually was. Across the country that amounts to about 500,000 more seniors receiving high-risk medications than health plans reported, according to the authors' calculations.

The study appears Sept. 30 in Annals of Internal Medicine.

The findings are based on a comparison of the rates the plans reported to the government's Healthcare Effectiveness Data and Information Set (HEDIS) for 2006 and 2007 with rates the researchers calculated for each plan during the same years, using data from Medicare Part D drug claims. The researchers used a random sample of about 1,000 patients enrolled in each of those plans.

In other words, the researchers compared what the plans said about their enrollees' receipt of high-risk drugs to their enrollees' actual receipt of risky drugs using the same plans' pharmacy data.

"We're using the same sources of data that Medicare Advantage plans are supposed to be using to derive this information," said lead author Alicia Cooper, a former Brown doctoral student who now works for the State of Vermont.

Advantageous inaccuracy

To motivate Medicare Advantage health plans to improve health care delivery, Medicare evaluates and pays the plans based in part on dozens of quality measures such as the rate of prescribing about 100 medicines deemed risky for seniors. Plans must report their data to HEDIS. That data is also made available to consumers who can use it to determine which plans provide the best quality care.

Corresponding author Dr. Amal Trivedi, associate professor of health services policy and practice at the Brown University School of Public Health, said it was notable that 95 percent of plans erred in their own favor, and that only nine of 172 plans came within 1 percent of the rate the researchers calculated.

"We can't say anything about motive, but the direction is important in that they underreport the use of these medications," said Trivedi, who is also a physician and researcher at the Providence V.A. Medical Center. "Their stated performance is much better than their actual performance."

In the study Trivedi, Cooper, and their co-authors ranked each plan based on its self-reported high-risk prescription rate and then on the high-risk prescription rate they calculated.

The more inaccurate a plan was in its own favor, the farther up the rankings it rose. The 18 plans that erred by more than 10 percentage points climbed an average of 49 rungs on the list based on self-reports, compared to where they ranked on the list based on calculated rates. The nine plans whose self reported rates were within 1 percent of the calculated rate ranked an average of 43 places lower on the calculated rate list than on the self-reported rate list.

"The plans that were the most accurate were the ones that suffered the greatest penalties when using the plan-reported rates," Trivedi said.

Trivedi also noted that the inaccuracies have skewed comparisons between Medicare Advantage plans and Medicare fee for service. His team's calculated rates show that Medicare Advantage is not decisively better, but instead that the two forms of Medicare coverage are very similar for high-risk prescription rates.

Questions about self-reporting

Cooper said she and Trivedi were motivated to look at the data not merely to learn about rates of high-risk prescribing but more generally to assess the accuracy of a self-reported, unaudited quality measure. Medicare policy and consumer choices depend on the integrity of that data.

High-risk prescribing provides a relatively easy way to assess self-reporting. The prescribing data are readily available from just a few public sources, the list of high-risk drugs is widely known, and the rules defining which patients to include are unambiguous.

"There is reason to believe that if there is inaccuracy in this relatively straightforward measure, there could be inaccuracy in other more complicated measures as well," Cooper said.

In their paper in Annals, the researchers suggest that the government may want to increase oversight of the data reported by Medicare Advantage plans.

"Policymakers should consider routine audits of publicly reported quality measures, including the HEDIS indicator of high-risk prescribing, to ensure the validity and reliability for patients and other stakeholders," they wrote.

Story Source:

The above story is based on materials provided by Brown University. Note: Materials may be edited for content and length.

Journal Reference:

  1. Alicia L. Cooper. Underreporting High-Risk Prescribing Among Medicare Advantage Plans. Annals of Internal Medicine, 2013; 159 (7): 456 DOI: 10.7326/0003-4819-159-7-201310010-00005

Cite This Page:

Brown University. "Medicare plans understate risky prescribing rates." ScienceDaily. ScienceDaily, 30 September 2013. <www.sciencedaily.com/releases/2013/09/130930200706.htm>.
Brown University. (2013, September 30). Medicare plans understate risky prescribing rates. ScienceDaily. Retrieved March 30, 2015 from www.sciencedaily.com/releases/2013/09/130930200706.htm
Brown University. "Medicare plans understate risky prescribing rates." ScienceDaily. www.sciencedaily.com/releases/2013/09/130930200706.htm (accessed March 30, 2015).

Share This

More From ScienceDaily

More Health & Medicine News

Monday, March 30, 2015

Featured Research

from universities, journals, and other organizations

Featured Videos

from AP, Reuters, AFP, and other news services

S. Leone in New Anti-Ebola Lockdown

S. Leone in New Anti-Ebola Lockdown

AFP (Mar. 28, 2015) Sierra Leone imposed a three-day nationwide lockdown Friday for the second time in six months in a bid to prevent a resurgence of the deadly Ebola virus. Duration: 01:17 Video provided by AFP
Powered by NewsLook.com
These Popular Antibiotics Can Cause Permanent Nerve Damage

These Popular Antibiotics Can Cause Permanent Nerve Damage

Newsy (Mar. 27, 2015) A popular class of antibiotic can leave patients in severe pain and even result in permanent nerve damage. Video provided by Newsy
Powered by NewsLook.com
WH Plan to Fight Antibiotic-Resistant Germs

WH Plan to Fight Antibiotic-Resistant Germs

AP (Mar. 27, 2015) The White House on Friday announced a five-year plan to fight the threat posed by antibiotic-resistant bacteria amid fears that once-treatable germs could become deadly. (March 27) Video provided by AP
Powered by NewsLook.com
House Ready to Pass Medicare Doc Bill

House Ready to Pass Medicare Doc Bill

AP (Mar. 26, 2015) In rare bipartisan harmony, congressional leaders pushed a $214 billion bill permanently blocking physician Medicare cuts toward House passage Thursday, moving lawmakers closer to resolving a problem that has plagued them for years. (March 26) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.


Breaking News:

Strange & Offbeat Stories

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News


Free Subscriptions

Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile

Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?

Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins